Laviceftra 500mg Injection
Marketer
Lavish Biotech
Salt Composition
Ceftriaxone (500mg)
Overview Laviceftra 500mg Injection
Ceftolozane/tazobactam 500mg injection, a cephalosporin antibiotic, combats various bacterial infections. Its applications span diverse sites including the central nervous system (meningitis), respiratory system (pneumonia), ears, urinary tract, skin and soft tissues, musculoskeletal system, bloodstream, and cardiovascular system. Prophylactic use is also indicated in surgical settings. Administered intravenously or intramuscularly by a healthcare provider, dosage is individualized. Regular, evenly-spaced dosing, as directed, is crucial; premature discontinuation may result in infection recurrence or exacerbation. Common adverse reactions encompass diarrhea, rash, altered liver function tests, and hematological changes (eosinophilia, leukopenia, thrombocytopenia). Local injection site erythema or pain may occur transiently. Report persistent or bothersome side effects. Prior to treatment, disclose any antibiotic allergies, hepatic or renal impairment, and a complete medication list to your physician, as drug interactions are possible.
Uses of Laviceftra 500mg Injection
Managing bacterial infections
Major Benefits of Laviceftra 500mg Injection:
Administering this medication will be done by your healthcare provider. Self-medication is not permitted.
Common Side effects of Laviceftra 500mg Injection:
- Diarrhea
- Abnormal liver function tests
- Rash
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count
- Low blood platelets
How to use Laviceftra 500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Laviceftra 500mg Injection works:
The antibiotic injection Laviceftra, 500mg, works by disrupting bacterial cell wall synthesis, thus eliminating the bacteria's protective barrier and leading to their demise.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Laviceftra 500mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Laviceftra, 500mg, presents a low risk to the fetus during pregnancy, according to the majority of research findings.
Breast feedingCAUTION
Administering Laviceftra 500mg Injection to breastfeeding mothers requires careful consideration. Mothers should temporarily discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Laviceftra 500mg Injection may induce drowsiness, blurred vision, or dizziness. Driving is contraindicated if these effects are experienced.
KidneySAFE IF PRESCRIBED
Laviceftra 500mg Injection can be administered to patients with kidney impairment without dosage modification. Nevertheless, disclosure of pre-existing kidney conditions to the prescribing physician is advised.
LiverCAUTION
For individuals with significant hepatic impairment, administering Laviceftra 500mg Injection requires careful consideration and potential dosage modification. Patients with mild to moderate liver disease, however, generally do not require dosage changes for this medication. A physician's consultation is advised.
What if you forget to take Laviceftra 500mg Injection :
Omitting a scheduled dose of Laviceftra 500mg Injection necessitates contacting your physician.
Facts to Know About Laviceftra 500mg Injection
| Label | Value |
|---|---|
| Chemical Type | Advanced Cephalosporins (Third and Fourth Generation) |
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently